Bharat Biotech starts phase III trials for COVAXIN
Published
Published
PM Modi will be proceeding to Bharat Biotech's facility located at Genome valley, a life sciences cluster about 20 km from the AF..
The Phase-III human trials of indigenous Covid-19 vaccine Covaxin began at All India Institute of Medical Science (AIIMS) in New..